It’s this inflammation of the lining of your nose that produces the telltale stuffiness sensation of chronic nasal congestion ...

in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The therapy met the co-primary endpoint of the WAYPOINT ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

November 08, 2024--(BUSINESS WIRE)--Positive high-level results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP ... significant and clinically ...

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

Complications Associated With Nasal Congestion If left untreated, chronic nasal congestion (nasal congestion that lasts longer than two or three weeks) could be a sign of a more serious conditions ...

often resulting from chronic inflammation. While these benign growths themselves are not harmful, they can lead to ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...

Am­gen and As­traZeneca said on Fri­day that their asth­ma drug Tezspire re­duced nasal con­ges­tion and the size of nasal ...

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...